MARATTO

article · African Journal of Midwifery and Women s Health

A cross-sectional study of meconium-stained amniotic fluid among women giving birth at a tertiary teaching hospital in Tanzania

In plain language

Meconium-stained amniotic fluid can lead to adverse health outcomes during birth. An investigation carried out at a tertiary teaching hospital in Tanzania evaluated the presence of bacterial infections in this fluid and their relationship to newborn outcomes. Among over two thousand births assessed, meconium-stained amniotic fluid occurred in nearly nine percent of cases, with almost seventy percent of those fluids showing signs of bacterial infection on Gram stain examination. Mixed bacterial forms were identified in over a third of infected cases. Newborns exposed to infected fluid faced significantly worse outcomes, including higher rates of neonatal intensive care admissions, increased fresh stillbirths, and low five-minute Apgar scores. The findings highlight serious risks associated with bacterial contamination, pointing to potential risks during vaginal examinations and supporting the administration of broad-spectrum antibiotics to affected mothers.

Key takeaways

  • Meconium-stained amniotic fluid was identified in 8.7 percent of the examined births, and 69.8 percent of these cases contained bacterial infections.
  • Mixed bacterial morphology was observed in 38.1 percent of the infected fluid samples.
  • Infants exposed to infected fluid had significantly higher rates of intensive care admission, fresh stillbirth, and low Apgar scores compared to uninfected cases.
  • The administration of parenteral broad-spectrum antibiotics to mothers with meconium-stained fluid is advised to mitigate neonatal morbidity.

Why it matters

When amniotic fluid is contaminated with meconium, the addition of bacterial infection sharply increases the danger of infant illness and stillbirth. Understanding how frequently these infections occur and recognising their severe effects can guide clinical guidelines. This knowledge encourages improved hygienic practices during labour, such as maintaining sterile conditions during examinations, and prompts timely antibiotic treatment to protect newborn lives.

Commercialisation angle

This research provides clinical and epidemiological evidence relevant to hospital protocols, antibiotic stewardship programmes, and maternal healthcare training. It points toward immediate practical adjustments in obstetric management, such as the use of parenteral broad-spectrum antibiotics and sterile examination procedures, rather than the development of a distinct commercial product. The findings are applied and tested in a clinical hospital setting to refine existing care guidelines.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

Background/Aims Meconium-stained amniotic fluid is associated with adverse perinatal outcomes, and occurs in approximately 7–22% of all live births. The aim of this study was to determine the proportion of births with infected meconium-stained amniotic fluid and explore associated bacteriological patterns and perinatal outcomes in a tertiary teaching hospital in Dar es Salaam, Tanzania. Methods This cross-sectional study was conducted at Muhimbili National Hospital between August and December 2018 with women at ≥28 weeks' gestation about to give birth to a singleton baby with longitudinal lie and cephalic presentation. A sample of fluid was collected from each woman and transported for Gram staining at a university teaching microbiology laboratory. Univariate and bivariate analysis were used to calculate associations between variables and meconium-stained amniotic fluid. Results In total, 222 (8.7%) women out of 2566 births had meconium-stained amniotic fluid, 155 of whom (69.8%) had infected meconium. Mixed bacterial morphology was found in 59 cases (38.1%). Newborns from infected meconium-stained amniotic fluid were more likely to be admitted to the neonatal intensive care unit (32.9% vs 7.5%, P<0.001), to be fresh stillbirth (15.5% vs 3.0%, P=0.008) and to have an Apgar score ≤7 at 5 minutes (38.7% vs 7.5%, P=0.001). Conclusions There is an increased risk of neonatal morbidity and mortality among mothers diagnosed with meconium-stained amniotic fluid. Detecting bacteria in the fluid raises concerns related to bacterial inoculation during routine obstetric vaginal examinations. Assessing antimicrobial culture and sensitivity pattern is highly recommended in future studies to improve current antimicrobial protocols when caring for babies born to mothers with meconium-stained amniotic fluid. Implications for practice Healthcare professionals supervising labour and birth should be aware of the risks of neonatal morbidity in cases of meconium-stained amniotic fluid. Parenteral broad-spectrum antibiotics should be given to mothers with this diagnosis before birth to reduce neonatal morbidity. Ensuring sterile vaginal examinations is important to reduce the chances of mixed bacterial inoculation.

Research topics

  • Neonatal Respiratory Health Research
  • Pregnancy and preeclampsia studies
  • Infant Nutrition and Health

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.12968/ajmw.2024.0017

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.